Skip to content
Guayusa & Kola Nut — Forest WisdomLesson 9 of 16

Biopiracy and Benefit-Sharing

Goal: After this lesson you can explain biopiracy as an economic problem and describe what benefit-sharing models offer instead. Subject: Economics | Run time: about 7 minutes

Quick recall

Last time we met the reciprocity economy. Two quick questions. One: what is social capital? The non-monetary value that comes from trust, reciprocity, and community bonds (Pendergrast, 2013). Two: how does reciprocity differ from cash? Reciprocity settles in trust and long-term obligation over time, while cash settles on the spot.

Why this matters

Now put a price on it. The global market for traditional plant medicine is huge, with estimates ranging from about 70 billion to 233 billion dollars a year, depending on how you define it (Grand View Research, 2024; Fortune Business Insights, 2024). And the World Health Organization estimates that about 80 percent of people in developing nations rely on plant-based medicines as their primary healthcare (World Health Organization, 2023). That is enormous value. The question for this lesson is simple. Who gets the money?

The idea

Often, not the people whose knowledge started it. That pattern has a name: biopiracy. It works like a pipeline. Traditional knowledge goes into corporate research, becomes a patent or a trademark, turns into a global product, and the returns flow right past the community that knew it first. The plant and the wisdom came from one place. The profit lands somewhere else. That is the economic problem at the center of this episode, and the huge market numbers are exactly what makes the stakes so high (Grand View Research, 2024; Fortune Business Insights, 2024).

So what is the fix? The main answer is benefit-sharing, an arrangement built to send value back to the originating community. A benefit-sharing model changes the deal in concrete ways. Instead of paying growers the bare commodity rate, it pays them roughly 3 to 5 times that rate. It requires consent before the knowledge is used, and it requires attribution, so the community is named, not erased. The relationship shifts from a one-way extraction to a partnership where the people who hold the knowledge actually profit from it.

There is a second lever, and it may be the most powerful one: value-added processing. The trick of old extraction economics was to buy raw material cheap, ship it out, and capture all the profit downstream where it is processed into a finished good. Value-added processing flips that. When a community processes its own raw material instead of exporting it unprocessed, it captures the margin that extraction historically removed. Think of dried guayusa tea, or guayusa extract. The community that dries the leaf or makes the extract keeps the markup that used to leave with the raw crop. Benefit-sharing raises the price they get for the harvest. Value-added processing lets them own more of the chain. Together, they turn a pipeline that drained value out into one that keeps value home.

Picture it

Picture two pipes running out of the forest. The first is the old one. Raw leaves go in one end, and out the far end comes a finished product on a shelf, with the profit pooling there, far from the people who grew it. Now picture the second pipe rebuilt. The drying and the extract-making happen at the source, the price paid for the harvest is several times higher, and the community's name is on the label. Same plant, but the value flows the other way.

Remember this

The fact to carry out: the traditional-medicine market is worth somewhere between about 70 billion and 233 billion dollars a year (Grand View Research, 2024; Fortune Business Insights, 2024), with roughly 80 percent of people in developing nations using plant medicines as primary care (World Health Organization, 2023), and benefit-sharing answers biopiracy by paying growers about 3 to 5 times the commodity rate, requiring consent and attribution, and letting communities capture margin through value-added processing.

Quick check

Quick check. Name one thing a benefit-sharing model does that a plain commodity sale does not. It pays growers about 3 to 5 times the commodity rate, and it requires consent and attribution (Grand View Research, 2024; Fortune Business Insights, 2024).

Key Takeaways

  • The global traditional-medicine market is estimated at about 70 billion to 233 billion dollars a year, depending on definition (Grand View Research, 2024; Fortune Business Insights, 2024).
  • The WHO estimates that about 80 percent of people in developing nations use plant-based medicines as primary healthcare (World Health Organization, 2023).
  • Biopiracy is the pattern where traditional knowledge becomes a corporate product and the returns flow past the originating community.
  • Benefit-sharing pays growers about 3 to 5 times the commodity rate and requires consent and attribution.
  • Value-added processing, like making dried guayusa tea or extract at the source, lets a community capture the margin that extraction historically removed.

Sources

Sign in to track your progress